Theravance Biopharma shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Theravance Biopharma
Tip: Access up to 7 years of quarterly data
All positions including Theravance Biopharma held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Theravance Biopharma by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $3.2M | 286k | 11.24 |
| 2023-09-30 | $2.3M | 270k | 8.63 |
| 2023-06-30 | $3.5M | 341k | 10.35 |
| 2023-03-31 | $3.7M | 336k | 10.85 |
| 2022-12-31 | $4.4M | 396k | 11.22 |
| 2022-06-30 | $5.3M | 583k | 9.06 |
| 2022-03-31 | $9.3M | 976k | 9.56 |
| 2021-12-31 | $3.8M | 344k | 11.05 |
| 2021-09-30 | $2.3M | 304k | 7.40 |
| 2021-03-31 | $5.7M | 281k | 20.41 |
| 2020-12-31 | $6.2M | 350k | 17.77 |
| 2020-09-30 | $4.7M | 315k | 14.79 |
| 2020-06-30 | $7.0M | 334k | 20.99 |
| 2019-12-31 | $3.0M | 117k | 25.89 |
| 2019-09-30 | $2.3M | 118k | 19.48 |
| 2019-06-30 | $4.0M | 245k | 16.33 |
| 2019-03-31 | $6.0M | 266k | 22.67 |
| 2018-12-31 | $6.0M | 235k | 25.58 |
| 2018-09-30 | $7.2M | 219k | 32.67 |
| 2018-06-30 | $5.0M | 223k | 22.68 |
| 2018-03-31 | $11M | 470k | 24.25 |
| 2017-12-31 | $5.5M | 198k | 27.89 |
| 2017-09-30 | $8.8M | 257k | 34.24 |
| 2017-06-30 | $9.5M | 239k | 39.84 |
| 2017-03-31 | $9.4M | 256k | 36.82 |
| 2016-12-31 | $1.9M | 58k | 31.89 |
| 2016-09-30 | $954k | 26k | 36.26 |
| 2016-06-30 | $360k | 16k | 22.67 |
| 2016-03-31 | $273k | 15k | 18.77 |
| 2015-12-31 | $309k | 19k | 16.41 |
| 2015-09-30 | $165k | 15k | 10.98 |